期刊文献+

uPA系统在4株非小细胞性肺癌细胞中的表达 被引量:2

The Expression of u P A Syste m in Four Non small Cell Lung Cancer Cell Line
下载PDF
导出
摘要 目的:研究尿激酶型纤溶酶原(u P A) 激活系统中4 种主要成分u P A、 P A I1 、 P A I2 、u P A R 在非小细胞性肺癌细胞株中的表达及各因子之间的作用方式。方法:应用免疫组化、蛋白免疫印迹技术对培养细胞中4 种成分进行定位、定性及半定量分析;应用斑点杂交技术检测4 种细胞中u P A m R N A 和u P A Rm R N A 的表达。结果:4 种成分在4 株细胞的胞浆及胞膜均有表达。蛋白免疫印迹法检测u P A、 P A I1 、 P A I2 、u P A R,4 株细胞均在约140 ku 和约80 ku 处出现特异性条带,且两种腺癌细胞的表达水平显著高于其他两株细胞。斑点杂交结果示4 株细胞中均有u P A m R N A 和u P A R m R N A 的表达。结论:此4 株细胞中均能合成与分泌u P A 系统的4 种主要成分,各因子以二联及三联复合物(u P A/ P A I1 、u P A/ P A I2 、u P A/u P A R、u P A/ P A I1/u P A R、u P A/ P A I2/u P A R) 的形式存在;u P A 系统的表达与这4 种细胞的恶性程度并不一致。 Objective : To study the expression and the reaction patterns ofthe main components ofthe u P Asystem(u P A, P A I 1 , P A I 2 ,u P A R)in non small celllung cancer celllines . Methods :u P Asystem was detected and analyzedusing immunohistochemistry and Western Blot. Dot blot hybridization was used to detect the expression of u P A, u P A Rm R N A. Results : The four components of u P Asystem were expressed in the plasma and membrane ofthe four celllines . Using Western blotto detectthe expression of u P A, P A I 1 , P A I 2 ,u P A R,specific appeared special bands near 80 ku and140 ku were observed , and the expression level of the two adenocarcinoma cell lines was significantly higher than theother two cell lines. Both u P Aand u P A R m R N A were expressed by the four celllines . Conclusions : The four compo nents of u P Asystem could be synthesized and secreted by allthe four celllines ,existed in duplet ortriplet form (u P A/ P A I 1 ,u P A/ P A I 2 ,u P A/u P A R,u P A/ P A I 1/u P A Rand u P A/ P A I 2/u P A R) . The expression of u P Asystem were notinconcomitance with the malignance ofthe celllines .
出处 《中山医科大学学报》 CSCD 1999年第3期174-177,共4页 Academic Journal of Sun Yat-sen University of Medical Sciences
基金 国家自然科学基金
关键词 肺癌 非小细胞肺癌 尿激酶 细胞培养 Subject headings urokinase carcinoma ,non small cell lung cells,cultured
  • 相关文献

参考文献3

共引文献2

同被引文献29

  • 1牛义凯,肖伟,朱媛媛.肺癌患者血浆尿激酶型纤溶酶原激活系统的研究[J].中国肺癌杂志,2006,9(4):369-372. 被引量:3
  • 2Ozdemir O, Emri S, Karakoca Y. et al. Fibrinolytic system in plasma and pleural fluid in malignant pleural mesothelioma.Thromb Res.1996,84(2) : 121-128.
  • 3Pappot H, Hoyer Hansen G, Ronne E. et al. Elevated plasma levels of urokinase plasminogen activator receptor in non small cell lung cancer patients. Eur J Cancer, 1997,33(6) : 867-872.
  • 4Robert C, Bolon I, Gazzeri S, et al. Expression of plasminogen activator inhibitors 1 and 2 in lung cancer and their role in tumor progression. Clin Cancer Res,1999,5(8) : 2094-2102.
  • 5Bolon I, Devouassoux M. Robert C, et al. Expression of urokinase type plasminogen activator, stromelysin 1, stromelysin 3, and matrilysin genes in lung carcinomas. Am J Pathol, 1997,150(5):1619-1629.
  • 6Shetty S, Idell S. Posttranscriptional regulation of plasminogen activator inhibitor-1 in human lung carcinoma cells in vitro. Am J Physiol Lung Cell Mol Physiol,2000,278(1) : L148-L156.
  • 7Gris JC, Schved JF, Marty Double C, et al. Immunohistochemical study of tumor cell-associated plasminogen activators and plasminogen activator inhibitors in lung carcinomas. Chest, 1993,104( 1 ) :813.
  • 8Wojtukiewicz MZ, Zacharski LR, Memoli VA, et al. Abnormal regulation of coagulation/fibrinolysis in small cell carcinoma of the lung. Cancer, 1990,65(3) : 481-485.
  • 9Yoshino H, Endo Y, Watanabe Y, et al. Significance of plasminogen activator inhibitor 2 as a prognostic marker in primary lung cancer: association of decreased plasminogen activator inhibitor 2 with lymph node metastasis. Br J Cancer. 1998,78(6) : 833-839.
  • 10Nekarda H, Schmitt M. Ulm K. et al. Prognostic impact of urokinasetype plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer. Cancer Res, 1994,54(11):2900-2907.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部